Dr. Trotman on BGB-3111 in Patients With Waldenstrom’s Macroglobulinemia

Judith Trotman, MD, clinical associate professor, medicine, Concord Clinical School, The University of Sydney, discusses results of a trial investigating BGB-3111 in patients with Waldenstrom’s macroglobulinemia (WM).

BGB-3111 is a very specific BTK inhibitor that has a very high, very… Continue reading →